Vaccines should be obtained from multiple sources

The last thing that we wanted to hear now was that Bangladesh should not expect to get the Oxford-AstraZeneca vaccine from India anytime soon. Bangladesh is likely to run out of its stock of 10.2 million doses by the end of May. Clearly, Serum Institute of India (SII) has defaulted on its part of the agreement that it signed with the Bangladesh government, under which it was supposed to supply 5 million doses of Covid -19 vaccines every month. Not surprisingly, the supply of the vaccine has been disrupted due to a shortage of raw materials and India's internal demand.